- Home
- KOD vs FORR Comparison
KOD vs FORR Comparison
Compare KOD & FORR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KOD
- FORR
- Stock Information
- Founded
- KOD 2009
- FORR 1983
- Country
- KOD United States
- FORR United States
- Employees
- KOD N/A
- FORR N/A
- Industry
- KOD Biotechnology: Biological Products (No Diagnostic Substances)
- FORR Diversified Commercial Services
- Sector
- KOD Health Care
- FORR Consumer Discretionary
- Exchange
- KOD Nasdaq
- FORR Nasdaq
- Market Cap
- KOD 198.4M
- FORR 193.5M
- IPO Year
- KOD 2018
- FORR 1996
- Fundamental
- Price
- KOD $10.57
- FORR $9.58
- Analyst Decision
- KOD Hold
- FORR
- Analyst Count
- KOD 4
- FORR 0
- Target Price
- KOD $11.25
- FORR N/A
- AVG Volume (30 Days)
- KOD 681.7K
- FORR 97.8K
- Earning Date
- KOD 08-13-2025
- FORR 07-31-2025
- Dividend Yield
- KOD N/A
- FORR N/A
- EPS Growth
- KOD N/A
- FORR N/A
- EPS
- KOD N/A
- FORR N/A
- Revenue
- KOD N/A
- FORR $412,103,000.00
- Revenue This Year
- KOD N/A
- FORR N/A
- Revenue Next Year
- KOD N/A
- FORR $2.04
- P/E Ratio
- KOD N/A
- FORR N/A
- Revenue Growth
- KOD N/A
- FORR N/A
- 52 Week Low
- KOD $1.92
- FORR $8.50
- 52 Week High
- KOD $11.60
- FORR $19.74
- Technical
- Relative Strength Index (RSI)
- KOD 77.63
- FORR 42.94
- Support Level
- KOD $7.69
- FORR $9.68
- Resistance Level
- KOD $8.45
- FORR $10.45
- Average True Range (ATR)
- KOD 0.83
- FORR 0.56
- MACD
- KOD 0.17
- FORR -0.07
- Stochastic Oscillator
- KOD 85.66
- FORR 10.70
About KOD Kodiak Sciences Inc
Kodiak Sciences Inc is a biopharmaceutical company specializing in novel therapeutics to treat high-prevalence retinal diseases. The product candidate of the company is BLA, which is a novel antibody biopolymer conjugate, in treatment-naive subjects with neovascular wet AMD. The pipeline products of the company include Tarcocimab tedromer, KSI-501, and KSI-101.
About FORR Forrester Research Inc.
Forrester Research Inc provides independent research, data, and advisory services. It operates through the following segments: The Research segment develops and delivers research, connect, and analytics products; The consulting segment includes the revenues and the related costs of the company's consulting organization, and the Events segment is engaged in developing and hosting in-person and virtual events.